Literature DB >> 8245461

Met-ase: cloning and distinct chromosomal location of a serine protease preferentially expressed in human natural killer cells.

M J Smyth1, T J Sayers, T Wiltrout, J C Powers, J A Trapani.   

Abstract

A cDNA clone encoding a human NK serine protease was obtained by screening a lambda-gt10 library from the Lopez NK leukemia with the rat natural killer Met-ase (RNK-Met-1) cDNA clone. In Northern blot analysis human Met-ase (Hu-Met-1) cDNA hybridized with a 0.9-kb mRNA in two human NK leukemia cell lines, unstimulated human PBMC, and untreated purified CD3-CD56+ large granular lymphocytes. Unlike other members of the granzyme family that are highly expressed in activated peripheral T cells, the Hu-Met-1 transcript was barely detected in a population of PMA and ionomycin or IL-2-treated high density T cells. Several in vitro cultured Burkitt lymphomas, chronic- and promyeloid leukemias, acute lymphoblastic leukemias, and colon and ovarian carcinomas and colon and ovarian carcinomas did not express Hu-Met-1 mRNA. Hu-Met-1 mRNA expression in a small number of human T cell tumor lines did not correlate with any particular phenotype or stage of development. The presence of Hu-Met-1 mRNA closely correlated with the Met-ase activity of cellular lysates prepared from these various human peripheral blood subsets and in vitro cultured cell lines. Met-ase activity detected in whole cell lysates of cytotoxic lymphocytes was associated with the cytoplasmic granules of these cells. The nucleotide sequence of the Hu-Met-1 cDNA clone encodes a predicted serine protease of 257 amino acids. The predicted protein is an active enzyme of 232 amino acids with a calculated unglycosylated m.w. of 27,100. Hu-Met-1 is 66% identical to RNK-Met-1 at the amino acid level. The human and rat mature protein sequences conserve the active site His, Asp, and Ser amino acids that form the catalytic triad of serine proteases, all 8 cysteine residues, and several amino acids critical in the formation of the substrate binding pocket. The gene for the Hu-Met-1 serine protease is located on chromosome 19, which distinguishes it from any other member of the human granzyme family.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245461

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  A quarter century of granzymes.

Authors:  C L Ewen; K P Kane; R C Bleackley
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

Review 2.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 3.  Granzyme M: behind enemy lines.

Authors:  S A H de Poot; N Bovenschen
Journal:  Cell Death Differ       Date:  2014-01-10       Impact factor: 15.828

4.  The natural killer cell serine protease gene Lmet1 maps to mouse chromosome 10.

Authors:  K Y Thia; N A Jenkins; D J Gilbert; N G Copeland; M J Smyth
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  The gene encoding a human natural killer cell granule serine protease, Met-ase 1, maps to chromosome 19p13.3.

Authors:  E Baker; G R Sutherland; M J Smyth
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Evidence for the existence of granzyme-like serine proteases in teleost cytotoxic cells.

Authors:  Kesavannair Praveen; Donald L Evans; Liliana Jaso-Friedmann
Journal:  J Mol Evol       Date:  2004-04       Impact factor: 2.395

7.  Cloning and expression of the recombinant mouse natural killer cell granzyme Met-ase-1.

Authors:  J M Kelly; M D O'Connor; M D Hulett; K Y Thia; M J Smyth
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

8.  Cloning and characterization of a novel NK cell-specific serine protease gene and its functional 5'-flanking sequences.

Authors:  M J Smyth; M D Hulett; K Y Thia; H A Young; T J Sayers; C R Carter; J A Trapani
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells.

Authors:  S Shresta; D M MacIvor; J W Heusel; J H Russell; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.

Authors:  S A H de Poot; K W Lai; L van der Wal; K Plasman; P Van Damme; A C Porter; K Gevaert; N Bovenschen
Journal:  Cell Death Differ       Date:  2013-11-01       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.